1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
Lundgren, Christine LU ; Bendahl, Pär-Ola LU ; Ehinger, Anna LU
; Hegardt, Cecilia
LU
; Larsson, Christer
LU
; Loman, Niklas
LU
; Malmberg, Martin
LU
; Olofsson, Helena
; Saal, Lao
LU
and Sjoblom, Tobias
, et al.
(2019)
In Breast Cancer Research and Treatment
p.1-9
- Contribution to journal › Article
- 2014
-
Mark
Abstract P2-10-28: The Prognostic Index, KiGE, Combining Proliferation, Histological Grade and Estrogen Receptor Status Challenges Gene Profiling – A Study in 1,854 Chemo-Naïve Women with N0/N1 Primary Breast Cancer.
Strand, C ; Bak, M ; Borgquist, S LU ; Chebil, G ; Falck, A-K ; Fjällskog, M-l ; Grabau, D LU ; Hedenfalk, I LU
; Jirström, K
LU
and Klintman, M
LU
, et al.
(2014)
In Cancer Research
72(24 Supplement).
- Contribution to journal › Published meeting abstract
-
Mark
Abstract P2-10-19: Are the mitotic factors Mitotic Activity Index (MAI) and Phosphohistone 3 (PPH3) stronger prognostic proliferation factors than Ki67 in node-negative breast cancer?
- Contribution to journal › Published meeting abstract
-
Mark
A Prognostic Index Composed of Progesterone Receptor Status, Tumour Size and S-phase Fraction, Predicts Survival in Node-Negative Breast Cancer Patients in a Large Multicentre Prospective Cohort Study.
- Contribution to journal › Published meeting abstract
- 2013
-
Mark
The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer.
Forsare, Carina LU
; Bak, Martin
; Borgquist, Signe
LU
; Chebil, Gunilla
; Falck, Anna-Karin
LU
; Fjällskog, Marie-Louise
; Grabau, Dorthe
LU
; Hedenfalk, Ingrid
LU
; Jirström, Karin
LU
and Klintman, Marie
LU
, et al.
(2013)
In SpringerPlus
2(1).
- Contribution to journal › Article
-
Mark
The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer.
Klintman, Marie LU ; Forsare, Carina LU
; Ahlin, Cecilia
; Beglerbegovic, Sanda
; Fjällskog, Marie-Louise
; Grabau, Dorthe
LU
; Gudlaugsson, Einar
; Janssen, Emiel A M
; Lövgren, Kristina
LU
and Skaland, Ivar
, et al.
(2013)
In PLoS ONE
8(12).
- Contribution to journal › Article
-
Mark
A prospective, multicenter validation study of a prognostic index composed of S-phase fraction, progesterone receptor status, and tumour size predicts survival in node-negative breast cancer patients: NNBC, the node-negative breast cancer trial.
- Contribution to journal › Article
- 2010
-
Mark
Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer.
- Contribution to journal › Article
-
Mark
The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer.
(2010) In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 23. p.251-259
- Contribution to journal › Article
- 2009
-
Mark
Validation of the predictive value of tissue inhibitor of metalloproteinases-1 for the response to first-line chemotherapy in metastatic breast cancer.
- Contribution to journal › Published meeting abstract